Start free

Angiodynamics Inc (ANGO) insider trading

Recent insider transactions reported to the SEC on Form 4 — directors and officers buying or selling their own company’s stock. Sourced directly from public SEC filings, latest filed Nov 4, 2026.

Filings shown
26
Open-market buys
0
Open-market sells
3

Counts cover the 26 most recent Form 4 filings Tradune holds for ANGO (filed Jul 21 – Nov 4, 2026); the score below covers only the trailing 90 days (0 buys, 2 sells). SEC EDGAR Form 4 filings for ANGO last checked Nov 21, 2026, 09:00 UTC; the latest ANGO filing Tradune holds was filed Nov 4, 2026. This is not guaranteed to be the complete record — see ANGO's full Form 4 filing history on SEC EDGAR.

Open-market activity, last 90 days

Purchases (Form 4 code P) and sales (code S) on the 2 filings Tradune holds for ANGO filed Oct 30 – Nov 4, 2026. Grants, exercises, tax withholding and the other Form 4 transaction codes are left out.

2 open-market sales by Rule 10b5-1 checkbox

On filings with the 10b5-1 box checked
0 sales· 0 sh
checkbox disclosed
On filings with the box not checked
2 sales· 25,335 sh
not proof that no plan exists
Not comparable
0 sales· 0 sh
filed before Apr 1, 2023, or no checkbox value in the filing data

Counts are Form 4 lines as filed. The checkbox is one per filing, so every sale on a filing with the box checked is counted there even if only some of its transactions were under a plan; it records what the filer disclosed, and the three categories are not a judgement about why a sale was made.

Open-market purchases and sales by insider
Insider Buys Sells Shares bought Shares sold Value
Stephen A. TrowbridgeEVP and CFO 0 2 — 25,335 −$310,688

Value = shares × the price reported on each Form 4 (+ purchases, − sales); every open-market line in this window disclosed a price.

Insider-activity score

0/ 100

Net insider sales
0 distinct buyers0 buy · 2 sell tx

Summarises ~90 days of public SEC Form 4 activity — more distinct buyers, officer involvement and net buying score higher. A description of filing activity, not a rating or buy signal. How this score is computed →

Get alerted when insiders buy the stocks you own

Add your holdings — no brokerage login — and Insider Radar sends a Telegram alert when an open-market Form 4 buy of $100,000 or more is filed on a stock you hold or watch.

Free for everyone right now · no card · nothing to buy

Start free

How to read this: an open-market purchase (Form 4 code P) is a buy at the market price with the insider’s own money, as opposed to a grant, award or option exercise; an open-market sale is code S. When two or more distinct insiders report open-market purchases in the same 90-day window, this site labels that a cluster — a definition, not a forecast; see insider cluster buying. “Held after” is Form 4 Table I column 5; “Change” = shares ÷ holdings before the trade (held after − shares for an acquisition, held after + shares for a disposition).

Insider Buying at ANGO

No open-market insider purchases (Form 4 code P) were reported for ANGO between Jul 21, 2026 and Nov 4, 2026. The filings below may include other transaction types — sales, grants, option exercises, and tax withholding — shown for completeness; they are not open-market purchases.

Recent Form 4 filings

Source: SEC EDGAR Form 4 · transaction codes explained

Eric Honroth President and CEO · filed Nov 4, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Performance Right 62,928 — — — Nov 2, 2026
Grant / award 38,265 — 101,193 +61% Nov 2, 2026
Grant / award 62,928 — 62,928 — Nov 2, 2026

† change in this filer’s own reported holding line (Form 4 Table I, col. 5), not of total company ownership; small prior holdings produce large percentages, so under 100 shares the prior holding is shown instead.

Stephen A. Trowbridge EVP and CFO · filed Oct 30, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box not checked 23,615 $12.27 280,461 −7.8% Oct 29, 2026
Open-market sale 10b5-1 box not checked 1,720 $12.17 304,076 −0.6% Oct 28, 2026

“10b5-1 box checked” = the filer checked the Form 4 box stating that a transaction on the filing was made under a plan intended to satisfy Rule 10b5-1(c); “10b5-1 box not checked” = the box was left blank, which does not prove that no plan exists. The box applies to Form 4s filed from April 1, 2023; older filings, and boxes we could not read, carry no tag. What the 10b5-1 box means.

Warren Nighan Jr. SVP Quality and Regulatory · filed Jul 31, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box not checked 23,370 $14.72 64,745 −27% Jul 30, 2026
Laura Piccinini SVP International · filed Jul 24, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 4,506 $13.82 81,929 −5.2% Jul 22, 2026
Option exercise 8,047 — 86,435 +10% Jul 22, 2026
Option exercise Performance Right 28,336 — — — Jul 22, 2026
Warren Nighan Jr. SVP Quality and Regulatory · filed Jul 24, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Option exercise Performance Right 20,052 — — — Jul 22, 2026
Tax withholding 1,671 $13.82 88,115 −1.9% Jul 22, 2026
Option exercise 5,694 — 89,786 +6.8% Jul 22, 2026
Stephen A. Trowbridge EVP and CFO · filed Jul 24, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Option exercise Performance Right 57,381 — — — Jul 22, 2026
Tax withholding 8,319 $13.82 305,796 −2.6% Jul 22, 2026
Option exercise 16,296 — 314,115 +5.5% Jul 22, 2026
James C. Clemmer President and CEO · filed Jul 24, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Option exercise Performance Right 184,361 — — — Jul 22, 2026
Tax withholding 26,728 $13.82 862,448 −3.0% Jul 22, 2026
Option exercise 52,358 — 889,176 +6.3% Jul 22, 2026
Chad Thomas Campbell SVP/GM, Vascular Access · filed Jul 24, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Option exercise Performance Right 22,768 — — — Jul 22, 2026
Tax withholding 2,330 $13.82 108,676 −2.1% Jul 22, 2026
Option exercise 6,466 — 111,006 +6.2% Jul 22, 2026
Jan Stern Reed Director · filed Jul 22, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 11,887 — 116,921 +11% Jul 15, 2026
Karen A. Licitra Director · filed Jul 22, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 11,887 — 102,322 +13% Jul 15, 2026
Wesley Johnson Director · filed Jul 22, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 11,887 — 155,425 +8.3% Jul 15, 2026
Howard W. Donnelly Director · filed Jul 22, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 11,887 — 178,938 +7.1% Jul 15, 2026
Lorinda Burgess Director · filed Jul 22, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 11,887 — 67,144 +22% Jul 15, 2026
Eileen O'Shea Auen Director · filed Jul 22, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 11,887 — 116,605 +11% Jul 15, 2026
Michael E. Tarnoff Director · filed Jul 22, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 11,887 — 95,265 +14% Jul 15, 2026
Stephen A. Trowbridge EVP and CFO · filed Jul 22, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 53,257 — 297,819 +22% Jul 15, 2026
Grant / award Performance Right 53,257 — — — Jul 15, 2026
Laura Piccinini SVP International · filed Jul 22, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 19,860 — 78,388 +34% Jul 15, 2026
Grant / award Performance Right 19,860 — — — Jul 15, 2026
Warren Nighan Jr. SVP Quality and Regulatory · filed Jul 22, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 17,966 — 84,092 +27% Jul 15, 2026
Grant / award Performance Right 17,966 — — — Jul 15, 2026
Chad Thomas Campbell SVP/GM, Vascular Access · filed Jul 22, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 16,081 — 104,540 +18% Jul 15, 2026
Grant / award Performance Right 16,081 — — — Jul 15, 2026
Lawrence T. Weiss SVP, Chief Legal Officer · filed Jul 22, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 21,288 — 112,618 +23% Jul 15, 2026
Grant / award Performance Right 21,288 — — — Jul 15, 2026
Stephen A. Trowbridge EVP and CFO · filed Jul 21, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 717 $13.71 244,562 −0.3% Jul 20, 2026
Tax withholding 3,510 $13.51 245,279 −1.4% Jul 17, 2026
Tax withholding 7,840 $14.14 248,789 −3.1% Jul 16, 2026
Laura Piccinini SVP International · filed Jul 21, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 616 $13.71 58,528 −1.0% Jul 20, 2026
Tax withholding 3,074 $13.51 59,144 −4.9% Jul 17, 2026
Tax withholding 4,538 $14.14 62,218 −6.8% Jul 16, 2026
Warren Nighan Jr. SVP Quality and Regulatory · filed Jul 21, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 251 $13.71 66,126 −0.4% Jul 20, 2026
Tax withholding 1,373 $13.51 66,377 −2.0% Jul 17, 2026
Tax withholding 2,153 $14.14 67,750 −3.1% Jul 16, 2026
James C. Clemmer President and CEO · filed Jul 21, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 4,223 $13.71 836,818 −0.5% Jul 20, 2026
Tax withholding 487 $13.51 841,041 −0.1% Jul 19, 2026
Tax withholding 11,764 $13.51 841,528 −1.4% Jul 19, 2026
Tax withholding 10,649 $13.51 853,292 −1.2% Jul 17, 2026
Tax withholding 18,588 $14.14 863,941 −2.1% Jul 16, 2026
Chad Thomas Campbell SVP/GM, Vascular Access · filed Jul 21, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 359 $13.71 88,459 −0.4% Jul 20, 2026
Tax withholding 1,112 $13.51 88,818 −1.2% Jul 17, 2026
Tax withholding 2,367 $14.14 89,930 −2.6% Jul 16, 2026

Listing the 25 most recent of 26 Form 4 filings held for ANGO; the 1 older filing (filed Jul 21 – Jul 21, 2026) is counted above but not listed here — see ANGO's full Form 4 filing history on SEC EDGAR.

Insider filings reported around the same time

Other companies whose most recent Form 4 was filed closest to ANGO's (Nov 4, 2026).

Frequently asked about ANGO insider activity

How many insiders bought ANGO stock in these Form 4 filings?

No open-market purchases (Form 4 code P) of ANGO shares were reported by Angiodynamics Inc insiders between Jul 21, 2026 and Nov 4, 2026. The 26 filings shown on this page cover other transaction types — sales, grants, option exercises, and tax withholding.

Who filed the most recent Form 4 for ANGO?

The most recent Form 4 on this page was filed by Eric Honroth (President and CEO) on Nov 4, 2026, reporting 3 transactions. The original document is linked from the filing list above on SEC EDGAR. Amended filings (Form 4/A) may later revise reported figures.

What was the largest open-market ANGO insider sale shown?

The largest open-market sale among the filings shown was 23,370 ANGO shares at $14.72 (about $344,006) by Warren Nighan Jr. (SVP Quality and Regulatory) on Jul 30, 2026. Value is shares × the price reported on the Form 4; its Rule 10b5-1 box is not checked.

New to Form 4s? The transaction codes, the 90-day window and the 0–100 score are defined on the insider-activity score methodology page.

Get insider alerts for ANGO — and your whole portfolio

Tradune watches SEC Form 4 filings and flags insider-cluster buying across everything you hold, routed to you automatically. Free for everyone right now · no card · nothing to buy

This score summarizes SEC Form 4 filing activity over the trailing 90 days. It is descriptive, not predictive — not a rating, recommendation, or investment advice. Data: SEC EDGAR (public domain), as filed; amendments may revise figures. Tradune is not a registered investment adviser.

Data as filed; amended filings (Form 4/A) may revise figures. Sales may occur under prearranged Rule 10b5-1 trading plans.